| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.531 | 0.075 | 0.797 | Antiinflammatory | 0.564 0.064 DBMET03567 0.797 0.016 DBMET03568 | DBMET03568 | |
| 0.431 | 0.042 | 0.431 | MAP kinase kinase 6 inhibitor | 0.361 0.084 DBMET03567 | ||
| 0.389 | 0.004 | 0.389 | Poly(ADP-ribose) polymerase inhibitor | 0.062 0.016 DBMET03567 | ||
| 0.384 | 0.013 | 0.384 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.255 0.047 DBMET03567 | ||
| 0.435 | 0.072 | 0.493 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.493 0.037 DBMET03567 | DBMET03567 | |
| 0.356 | 0.005 | 0.356 | Toll-Like receptor antagonist | 0.283 0.009 DBMET03567 0.163 0.047 DBMET03568 | ||
| 0.354 | 0.004 | 0.354 | I kappa B kinase inhibitor | 0.097 0.041 DBMET03567 | ||
| 0.333 | 0.004 | 0.333 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.053 0.016 DBMET03567 | ||
| 0.334 | 0.006 | 0.334 | Cyclin-dependent kinase 8 inhibitor | 0.188 0.044 DBMET03567 | ||
| 0.349 | 0.038 | 0.349 | HERG channel blocker | |||
| 0.315 | 0.019 | 0.315 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.262 0.051 DBMET03567 | ||
| 0.361 | 0.082 | 0.391 | Antiobesity | 0.391 0.069 DBMET03567 0.381 0.073 DBMET03568 | DBMET03567 | |
| 0.368 | 0.099 | 0.368 | Analgesic | 0.362 0.102 DBMET03567 0.222 0.211 DBMET03568 | ||
| 0.278 | 0.013 | 0.278 | MAP kinase kinase 3 inhibitor | 0.203 0.113 DBMET03567 | ||
| 0.265 | 0.003 | 0.265 | I kappa B kinase 2 inhibitor | 0.067 0.035 DBMET03567 | ||
| 0.288 | 0.053 | 0.288 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.278 | 0.043 | 0.278 | MAP-kinase-activated kinase 5 inhibitor | 0.188 0.119 DBMET03567 | ||
| 0.235 | 0.024 | 0.235 | Activin receptor-like kinase 2 inhibitor | |||
| 0.213 | 0.004 | 0.213 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.216 | 0.014 | 0.216 | Check point kinase 2 inhibitor | |||
| 0.213 | 0.012 | 0.213 | Activin receptor-like kinase 4 inhibitor | 0.126 0.045 DBMET03567 | ||
| 0.202 | 0.013 | 0.202 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.068 0.063 DBMET03567 | ||
| 0.188 | 0.005 | 0.188 | Toll-Like receptor 7 antagonist | 0.162 0.005 DBMET03567 0.06 0.055 DBMET03568 | ||
| 0.231 | 0.056 | 0.231 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.231 | 0.059 | 0.231 | Tyrosine kinase inhibitor | |||
| 0.174 | 0.006 | 0.174 | Bruton tyrosine kinase inhibitor | |||
| 0.204 | 0.038 | 0.204 | Protein kinase (CK1) inhibitor | |||
| 0.199 | 0.036 | 0.199 | Toll-Like receptor 9 antagonist | 0.127 0.08 DBMET03567 | ||
| 0.201 | 0.04 | 0.201 | Tyrosine-protein kinase receptor antagonist | |||
| 0.258 | 0.101 | 0.258 | Nootropic | 0.238 0.118 DBMET03567 | ||
| 0.19 | 0.033 | 0.19 | TRKA antagonist | |||
| 0.166 | 0.013 | 0.166 | Acetylcholine nicotinic agonist | 0.158 0.015 DBMET03567 | ||
| 0.178 | 0.025 | 0.178 | MAP kinase kinase 4 inhibitor | 0.161 0.044 DBMET03567 | ||
| 0.169 | 0.016 | 0.169 | Protein kinase C zeta inhibitor | 0.094 0.059 DBMET03567 | ||
| 0.166 | 0.019 | 0.166 | Phosphodiesterase IV inhibitor | 0.072 0.07 DBMET03567 | ||
| 0.162 | 0.018 | 0.162 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.156 | 0.013 | 0.156 | MAP-kinase-activated kinase inhibitor | 0.13 0.022 DBMET03567 | ||
| 0.133 | 0.005 | 0.133 | Toll-Like receptor 8 antagonist | 0.081 0.017 DBMET03567 | ||
| 0.141 | 0.013 | 0.141 | MAP-kinase-activated kinase 2 inhibitor | 0.122 0.019 DBMET03567 | ||
| 0.205 | 0.079 | 0.205 | Anticonvulsant | 0.149 0.13 DBMET03567 | ||
| 0.143 | 0.019 | 0.143 | Glutamate receptor agonist | 0.137 0.021 DBMET03567 | ||
| 0.176 | 0.056 | 0.251 | Diuretic | 0.251 0.03 DBMET03567 0.205 0.042 DBMET03568 | DBMET03567 | |
| 0.141 | 0.023 | 0.141 | 5 Hydroxytryptamine agonist | |||
| 0.178 | 0.061 | 0.178 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.122 | 0.005 | 0.132 | Nicotinic receptor alpha4 subunit antagonist | 0.132 0.005 DBMET03567 0.063 0.02 DBMET03568 | DBMET03567 | |
| 0.284 | 0.171 | 0.361 | Calcium channel L-type activator | 0.361 0.109 DBMET03567 | DBMET03567 | |
| 0.192 | 0.08 | 0.192 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.2 | 0.088 | 0.2 | EphB2 antagonist | |||
| 0.121 | 0.01 | 0.121 | Transforming growth factor beta 3 antagonist | 0.096 0.029 DBMET03567 | ||
| 0.135 | 0.023 | 0.135 | Pim-3 kinase inhibitor | |||
| 0.162 | 0.052 | 0.162 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.191 | 0.082 | 0.191 | Histone acetyltransferase inhibitor | 0.157 0.129 DBMET03567 | ||
| 0.199 | 0.093 | 0.199 | Potassium channel blocker | |||
| 0.124 | 0.019 | 0.124 | Check point kinase 1 inhibitor | 0.064 0.052 DBMET03567 | ||
| 0.121 | 0.016 | 0.121 | Janus tyrosine kinase 1 inhibitor | |||
| 0.166 | 0.062 | 0.166 | Protein kinase C nu inhibitor | |||
| 0.107 | 0.007 | 0.107 | Cyclin A1 inhibitor | 0.057 0.046 DBMET03567 | ||
| 0.158 | 0.058 | 0.158 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.112 | 0.016 | 0.112 | Transforming growth factor antagonist | 0.072 0.045 DBMET03567 | ||
| 0.212 | 0.117 | 0.212 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.156 | 0.061 | 0.439 | Hemostatic | 0.206 0.03 DBMET03567 0.439 0.006 DBMET03568 | DBMET03568 | |
| 0.106 | 0.011 | 0.106 | Nicotinic neuronal receptor agonist | 0.051 0.044 DBMET03567 | ||
| 0.136 | 0.043 | 0.136 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.136 | 0.047 | 0.136 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.164 | 0.075 | 0.164 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.131 | 0.043 | 0.131 | GABA C receptor antagonist | 0.122 0.051 DBMET03567 | ||
| 0.093 | 0.009 | 0.093 | 5 Hydroxytryptamine 2C agonist | 0.066 0.017 DBMET03567 | ||
| 0.122 | 0.039 | 0.122 | GABA C receptor rho-1 antagonist | 0.119 0.041 DBMET03567 | ||
| 0.107 | 0.026 | 0.107 | Protein kinase B alpha inhibitor | |||
| 0.164 | 0.085 | 0.164 | CDC-like kinase 2 inhibitor | |||
| 0.145 | 0.066 | 0.145 | Histone deacetylase SIRT1 inhibitor | |||
| 0.164 | 0.087 | 0.245 | Lipocortins synthesis antagonist | 0.245 0.035 DBMET03567 0.179 0.072 DBMET03568 | DBMET03567 | |
| 0.094 | 0.016 | 0.094 | Pim-2 kinase inhibitor | |||
| 0.157 | 0.08 | 0.157 | Heat shock protein 90 alpha antagonist | |||
| 0.115 | 0.039 | 0.115 | Acetylcholine agonist | 0.107 0.042 DBMET03567 | ||
| 0.077 | 0.005 | 0.077 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.096 | 0.026 | 0.096 | CDC7 inhibitor | |||
| 0.233 | 0.164 | 0.233 | Toll-Like receptor 7 agonist | |||
| 0.123 | 0.054 | 0.123 | Polo-like kinase-4 inhibitor | |||
| 0.145 | 0.076 | 0.145 | MAP kinase 3 inhibitor | |||
| 0.09 | 0.024 | 0.09 | MAP kinase kinase 7 inhibitor | 0.078 0.053 DBMET03567 | ||
| 0.231 | 0.166 | 0.231 | Toll-Like receptor agonist | |||
| 0.068 | 0.005 | 0.068 | Transforming growth factor beta 2 antagonist | 0.044 0.009 DBMET03567 | ||
| 0.12 | 0.057 | 0.12 | GABA receptor agonist | 0.095 0.084 DBMET03567 | ||
| 0.209 | 0.147 | 0.209 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.135 | 0.074 | 0.181 | Farnesoid X receptor antagonist | 0.181 0.029 DBMET03567 0.121 0.102 DBMET03568 | DBMET03567 | |
| 0.164 | 0.103 | 0.164 | MAP kinase kinase 5 inhibitor | |||
| 0.096 | 0.035 | 0.114 | Nicotinic alpha4beta2 receptor antagonist | 0.114 0.021 DBMET03567 | DBMET03567 | |
| 0.084 | 0.024 | 0.084 | Adrenaline uptake inhibitor | 0.079 0.027 DBMET03567 | ||
| 0.096 | 0.038 | 0.096 | 3C-Like protease (SARS coronavirus) inhibitor | 0.095 0.039 DBMET03567 | ||
| 0.108 | 0.05 | 0.108 | Pim-1 kinase inhibitor | |||
| 0.097 | 0.04 | 0.097 | GABA A receptor agonist | 0.077 0.069 DBMET03567 | ||
| 0.107 | 0.05 | 0.107 | Protein kinase C mu inhibitor | 0.091 0.066 DBMET03568 | ||
| 0.072 | 0.017 | 0.136 | Myc inhibitor | 0.136 0.005 DBMET03567 0.071 0.018 DBMET03568 | DBMET03567 | |
| 0.114 | 0.061 | 0.114 | 5 Hydroxytryptamine 3A agonist | |||
| 0.13 | 0.078 | 0.13 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.084 | 0.035 | 0.084 | MAP3K7 inhibitor | |||
| 0.121 | 0.072 | 0.121 | Protein kinase (CK1) delta inhibitor | |||
| 0.159 | 0.11 | 0.159 | I kappa B kinase epsilon inhibitor | 0.157 0.112 DBMET03567 | ||
| 0.09 | 0.041 | 0.09 | Janus tyrosine kinase 2 inhibitor | |||
| 0.12 | 0.073 | 0.12 | TRKB antagonist | |||
| 0.076 | 0.034 | 0.076 | Cyclin A inhibitor | |||
| 0.197 | 0.157 | 0.234 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.098 DBMET03567 | DBMET03567 | |
| 0.073 | 0.034 | 0.073 | 5 Hydroxytryptamine 2A agonist | |||
| 0.118 | 0.08 | 0.148 | Toll-Like receptor 2 antagonist | 0.148 0.054 DBMET03567 | DBMET03567 | |
| 0.074 | 0.036 | 0.074 | Cyclin A2 inhibitor | |||
| 0.077 | 0.039 | 0.077 | I kappa B kinase 1 inhibitor | |||
| 0.076 | 0.039 | 0.076 | Phosphodiesterase 4B inhibitor | |||
| 0.157 | 0.12 | 0.157 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.127 | 0.09 | 0.127 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.132 | 0.095 | 0.132 | Heat shock protein 90 antagonist | |||
| 0.104 | 0.069 | 0.104 | Protein kinase C gamma inhibitor | |||
| 0.048 | 0.014 | 0.048 | 5 Hydroxytryptamine 2B agonist | |||
| 0.072 | 0.039 | 0.072 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.121 | 0.089 | 0.121 | Protein kinase (CK1) gamma inhibitor | |||
| 0.133 | 0.102 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.093 | 0.063 | 0.098 | Prolactin inhibitor | 0.098 0.057 DBMET03567 | DBMET03567 | |
| 0.071 | 0.041 | 0.071 | Tyk2 inhibitor | |||
| 0.067 | 0.039 | 0.067 | Glutamate (mGluR) agonist | |||
| 0.076 | 0.048 | 0.076 | Histone deacetylase stimulant | 0.07 0.055 DBMET03568 | ||
| 0.076 | 0.048 | 0.076 | Histone deacetylase SIRT1 stimulant | 0.07 0.055 DBMET03568 | ||
| 0.056 | 0.029 | 0.056 | Transforming growth factor beta 1 antagonist | |||
| 0.045 | 0.018 | 0.045 | Somatostatin 4 agonist | 0.033 0.032 DBMET03567 | ||
| 0.067 | 0.041 | 0.067 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.074 | 0.05 | 0.074 | Protein kinase B beta inhibitor | |||
| 0.071 | 0.048 | 0.071 | Syk tyrosine kinase inhibitor | |||
| 0.055 | 0.033 | 0.055 | Dipeptidyl peptidase inhibitor | |||
| 0.052 | 0.03 | 0.053 | Dopamine transporter inhibitor | 0.053 0.03 DBMET03567 | DBMET03567 | |
| 0.102 | 0.082 | 0.102 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.082 | 0.063 | 0.088 | Myeloperoxidase inhibitor | 0.088 0.052 DBMET03567 | DBMET03567 | |
| 0.098 | 0.081 | 0.098 | 5 Hydroxytryptamine antagonist | |||
| 0.209 | 0.192 | 0.433 | Histamine release inhibitor | 0.419 0.066 DBMET03567 0.433 0.059 DBMET03568 | DBMET03568 | |
| 0.048 | 0.034 | 0.048 | Histamine H4 receptor antagonist | |||
| 0.068 | 0.054 | 0.068 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.07 | 0.056 | 0.07 | Rho-associated kinase II inhibitor | |||
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.031 | 0.02 | 0.031 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.13 | 0.12 | 0.13 | TRKC antagonist | |||
| 0.112 | 0.103 | 0.112 | Vascular endothelial growth factor 3 antagonist | |||
| 0.089 | 0.08 | 0.229 | GABA C receptor agonist | 0.229 0.016 DBMET03567 | DBMET03567 | |
| 0.087 | 0.078 | 0.087 | MAP kinase 8 inhibitor | |||
| 0.051 | 0.042 | 0.051 | Nicotinic alpha7 receptor agonist | |||
| 0.142 | 0.135 | 0.142 | Death-associated protein kinase 3 inhibitor | |||
| 0.081 | 0.074 | 0.081 | Hepatocyte growth factor antagonist | |||
| 0.045 | 0.038 | 0.045 | Aldosterone antagonist | |||
| 0.051 | 0.044 | 0.051 | Lysine-specific demethylase 1A inhibitor | |||
| 0.029 | 0.023 | 0.029 | Dipeptidyl peptidase I inhibitor | |||
| 0.059 | 0.055 | 0.071 | Neuronal nicotinic receptor antagonist | 0.071 0.044 DBMET03567 | DBMET03567 | |
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.063 | 0.06 | 0.063 | Janus tyrosine kinase 3 inhibitor | |||
| 0.064 | 0.063 | 0.064 | Histone deacetylase SIRT2 inhibitor | |||
| 0.093 | 0.092 | 0.093 | Aurora-B kinase inhibitor | |||
| 0.049 | 0.048 | 0.049 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.048 | 0.048 | 0.054 | GABA receptor antagonist | 0.054 0.038 DBMET03567 | DBMET03567 | |
| 0.182 | 0.185 | 0.397 | Immunomodulator | 0.397 0.045 DBMET03568 | DBMET03568 | |
| 0.067 | 0.073 | 0.082 | Acetylcholine nicotinic antagonist | 0.082 0.052 DBMET03567 | DBMET03567 | |
| 0.085 | 0.093 | 0.126 | Protein kinase (CK2) alpha inhibitor | 0.126 0.058 DBMET03567 | DBMET03567 | |
| 0.009 | 0.017 | 0.012 | 3C-Like protease (MERS coronavirus) inhibitor | 0.012 0.008 DBMET03567 | DBMET03567 | |
| 0.062 | 0.072 | 0.069 | Phospholipase D inhibitor | 0.069 0.054 DBMET03567 | DBMET03567 | |
| 0.042 | 0.054 | 0.051 | GABA A receptor antagonist | 0.051 0.04 DBMET03567 | DBMET03567 | |
| 0.034 | 0.048 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 DBMET03567 | DBMET03567 | |
| 0.023 | 0.037 | 0.041 | Purinergic P2Y14 antagonist | 0.041 0.011 DBMET03567 | DBMET03567 | |
| 0.036 | 0.049 | 0.043 | GABA B receptor antagonist | 0.043 0.028 DBMET03567 | DBMET03567 | |
| 0.058 | 0.072 | 0.065 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET03567 0.065 0.058 DBMET03568 | DBMET03568 | |
| 0.133 | 0.147 | 0.164 | Phospholipase C inhibitor | 0.164 0.082 DBMET03567 | DBMET03567 | |
| 0.09 | 0.109 | 0.123 | Glutamate receptor antagonist | 0.123 0.071 DBMET03567 | DBMET03567 | |
| 0.078 | 0.107 | 0.113 | Bile acid receptor antagonist | 0.113 0.027 DBMET03567 | DBMET03567 | |
| 0.059 | 0.093 | 0.072 | Protein kinase A inhibitor | 0.072 0.069 DBMET03568 | DBMET03568 | |
| 0.111 | 0.155 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.092 DBMET03567 | DBMET03567 | |
| 0.027 | 0.072 | 0.071 | AMPA receptor antagonist | 0.071 0.02 DBMET03567 | DBMET03567 | |
| 0.037 | 0.098 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | 0.065 0.021 DBMET03567 | DBMET03567 | |
| 0.073 | 0.137 | 0.167 | Toll-Like receptor 4 antagonist | 0.095 0.078 DBMET03567 0.167 0.014 DBMET03568 | DBMET03568 | |
| 0.007 | 0.073 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 DBMET03567 | DBMET03567 | |
| 0.049 | 0.134 | 0.093 | Protein kinase (CK2) inhibitor | 0.093 0.07 DBMET03567 | DBMET03567 | |
| 0.03 | 0.122 | 0.063 | Factor IXa inhibitor | 0.063 0.024 DBMET03568 | DBMET03568 | |
| 0.082 | 0.179 | 0.185 | Anticoagulant | 0.185 0.059 DBMET03568 | DBMET03568 | |
| 0.102 | 0.205 | 0.132 | Antipruritic | 0.132 0.12 DBMET03567 | DBMET03567 | |
| 0.02 | 0.131 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.032 DBMET03567 | DBMET03567 | |
| 0.199 | 0.31 | 0.272 | 5 Hydroxytryptamine release inhibitor | 0.272 0.198 DBMET03567 | DBMET03567 | |
| 0.02 | 0.14 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.024 DBMET03568 | DBMET03568 | |
| 0.026 | 0.155 | 0.041 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET03567 | DBMET03567 | |
| 0.023 | 0.167 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.021 DBMET03568 | DBMET03568 | |
| 0.106 | 0.257 | 0.22 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.138 DBMET03567 0.22 0.08 DBMET03568 | DBMET03568 | |
| 0.014 | 0.166 | 0.045 | GABA uptake inhibitor | 0.045 0.02 DBMET03567 | DBMET03567 | |
| 0.072 | 0.236 | 0.146 | Arachidonic acid antagonist | 0.146 0.093 DBMET03567 | DBMET03567 | |
| 0.087 | 0.265 | 0.346 | Tumour necrosis factor alpha release inhibitor | 0.346 0.039 DBMET03568 | DBMET03568 | |
| 0.081 | 0.265 | 0.276 | Platelet antagonist | 0.276 0.062 DBMET03568 | DBMET03568 | |
| 0.063 | 0.25 | 0.115 | Protein kinase stimulant | 0.115 0.099 DBMET03568 | DBMET03568 | |
| 0.119 | 0.309 | 0.292 | Peptidyltransferase inhibitor | 0.292 0.027 DBMET03568 | DBMET03568 | |
| 0.101 | 0.294 | 0.169 | Superoxide dismutase inhibitor | 0.169 0.157 DBMET03567 | DBMET03567 | |
| 0.023 | 0.22 | 0.067 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 DBMET03568 | DBMET03568 | |
| 0.076 | 0.28 | 0.267 | Spasmolytic | 0.267 0.084 DBMET03568 | DBMET03568 | |
| 0.082 | 0.289 | 0.353 | Vasodilator | 0.353 0.032 DBMET03568 | DBMET03568 | |
| 0.036 | 0.245 | 0.084 | Creatine kinase inhibitor | 0.084 0.08 DBMET03567 | DBMET03567 | |
| 0.045 | 0.257 | 0.22 | Thrombolytic | 0.22 0.043 DBMET03568 | DBMET03568 | |
| 0.109 | 0.327 | 0.526 | Antithrombotic | 0.526 0.026 DBMET03568 | DBMET03568 | |
| 0.035 | 0.271 | 0.058 | Lipocortins synthesis agonist | 0.058 0.04 DBMET03568 | DBMET03568 | |
| 0.064 | 0.313 | 0.19 | DNA methylase inhibitor | 0.19 0.086 DBMET03568 | DBMET03568 | |
| 0.038 | 0.288 | 0.101 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.101 0.053 DBMET03567 0.09 0.066 DBMET03568 | DBMET03567 | |
| 0.123 | 0.38 | 0.398 | Interleukin 2 agonist | 0.398 0.028 DBMET03568 | DBMET03568 | |
| 0.062 | 0.346 | 0.224 | Insulin secretagoues | 0.224 0.026 DBMET03568 | DBMET03568 | |
| 0.013 | 0.303 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.035 DBMET03568 | DBMET03568 | |
| 0.062 | 0.355 | 0.256 | Non-steroidal antiinflammatory agent | 0.256 0.04 DBMET03568 | DBMET03568 | |
| 0.036 | 0.333 | 0.269 | Amylase inhibitor | 0.269 0.023 DBMET03568 | DBMET03568 | |
| 0.031 | 0.329 | 0.177 | AMP-activated protein kinase stimulant | 0.177 0.015 DBMET03568 | DBMET03568 | |
| 0.011 | 0.313 | 0.041 | Dihydroorotase inhibitor | 0.041 0.036 DBMET03567 | DBMET03567 | |
| 0.052 | 0.357 | 0.153 | DNA methyltransferase I inhibitor | 0.148 0.106 DBMET03567 0.153 0.101 DBMET03568 | DBMET03568 | |
| 0.013 | 0.322 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03568 | DBMET03568 | |
| 0.071 | 0.386 | 0.471 | Transcription factor NF kappa B inhibitor | 0.471 0.049 DBMET03568 | DBMET03568 | |
| 0.091 | 0.42 | 0.261 | Sodium/bile acid cotransporter inhibitor | 0.261 0.117 DBMET03567 | DBMET03567 | |
| 0.089 | 0.421 | 0.153 | CC chemokine 6 receptor antagonist | 0.148 0.025 DBMET03567 0.153 0.019 DBMET03568 | DBMET03568 | |
| 0.06 | 0.405 | 0.14 | Interferon gamma antagonist | 0.14 0.093 DBMET03568 | DBMET03568 | |
| 0.109 | 0.454 | 0.607 | Cyclophilin D inhibitor | 0.261 0.2 DBMET03567 0.607 0.026 DBMET03568 | DBMET03568 | |
| 0.085 | 0.434 | 0.574 | Antibacterial | 0.248 0.179 DBMET03567 0.574 0.024 DBMET03568 | DBMET03568 | |
| 0.078 | 0.44 | 0.356 | Vasodilator, peripheral | 0.214 0.16 DBMET03567 0.356 0.071 DBMET03568 | DBMET03568 | |
| 0.037 | 0.41 | 0.089 | Phosphodiesterase 6D inhibitor | 0.089 0.078 DBMET03568 | DBMET03568 | |
| 0.005 | 0.414 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET03568 | DBMET03568 | |
| 0.048 | 0.459 | 0.18 | NOS3 expression enhancer | 0.18 0.05 DBMET03568 | DBMET03568 | |
| 0.039 | 0.455 | 0.361 | Platelet adhesion inhibitor | 0.361 0.017 DBMET03568 | DBMET03568 | |
| 0.054 | 0.471 | 0.411 | Immunosuppressant | 0.411 0.058 DBMET03568 | DBMET03568 | |
| 0.016 | 0.438 | 0.138 | Topoisomerase I inhibitor | 0.138 0.046 DBMET03568 | DBMET03568 | |
| 0.011 | 0.434 | 0.086 | Lipase inhibitor | 0.086 0.037 DBMET03568 | DBMET03568 | |
| 0.018 | 0.445 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 DBMET03568 | DBMET03568 | |
| 0.028 | 0.468 | 0.471 | Angiogenesis stimulant | 0.471 0.014 DBMET03568 | DBMET03568 | |
| 0.081 | 0.532 | 0.477 | Apoptosis agonist | 0.477 0.082 DBMET03568 | DBMET03568 | |
| 0.033 | 0.486 | 0.24 | Antiamyloidogenic | 0.24 0.075 DBMET03568 | DBMET03568 | |
| 0.019 | 0.51 | 0.124 | Beta glucuronidase inhibitor | 0.124 0.042 DBMET03568 | DBMET03568 | |
| 0.029 | 0.524 | 0.103 | Cyclooxygenase 3 inhibitor | 0.103 0.099 DBMET03568 | DBMET03568 | |
| 0.056 | 0.552 | 0.259 | Vasodilator, coronary | 0.259 0.126 DBMET03568 | DBMET03568 | |
| 0.006 | 0.504 | 0.215 | Selectin antagonist | 0.215 0.01 DBMET03568 | DBMET03568 | |
| 0.018 | 0.518 | 0.099 | Uric acid excretion stimulant | 0.096 0.057 DBMET03567 0.099 0.054 DBMET03568 | DBMET03568 | |
| 0.012 | 0.512 | 0.05 | Antibiotic Aminoglycoside-like | 0.05 0.013 DBMET03568 | DBMET03568 | |
| 0.067 | 0.568 | 0.363 | Apoptosis antagonist | 0.363 0.05 DBMET03568 | DBMET03568 | |
| 0.064 | 0.579 | 0.206 | Caspase 3 stimulant | 0.206 0.16 DBMET03568 | DBMET03568 | |
| 0.012 | 0.541 | 0.058 | Heparanase inhibitor | 0.058 0.027 DBMET03568 | DBMET03568 | |
| 0.027 | 0.563 | 0.271 | DNA synthesis inhibitor | 0.271 0.055 DBMET03568 | DBMET03568 | |
| 0.018 | 0.558 | 0.298 | Immunostimulant | 0.298 0.079 DBMET03568 | DBMET03568 | |
| 0.027 | 0.583 | 0.303 | Nitric oxide antagonist | 0.303 0.04 DBMET03568 | DBMET03568 | |
| 0.022 | 0.581 | 0.138 | Cell wall synthesis inhibitor | 0.138 0.077 DBMET03568 | DBMET03568 | |
| 0.012 | 0.575 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET03568 | DBMET03568 | |
| 0.02 | 0.595 | 0.105 | Cell adhesion inhibitor | 0.105 0.08 DBMET03568 | DBMET03568 | |
| 0.005 | 0.582 | 0.113 | Protein-tyrosine phosphatase 1B inhibitor | 0.113 0.068 DBMET03568 | DBMET03568 | |
| 0.01 | 0.589 | 0.138 | Protein-tyrosine phosphatase inhibitor | 0.138 0.091 DBMET03568 | DBMET03568 | |
| 0.034 | 0.632 | 0.318 | Hepatoprotectant | 0.318 0.025 DBMET03568 | DBMET03568 | |
| 0.014 | 0.645 | 0.379 | Free radical scavenger | 0.379 0.033 DBMET03568 | DBMET03568 | |
| 0.008 | 0.654 | 0.064 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 DBMET03568 | DBMET03568 | |
| 0.004 | 0.65 | 0.078 | Antineoplastic antibiotic | 0.078 0.059 DBMET03568 | DBMET03568 | |
| 0.015 | 0.675 | 0.414 | Antioxidant | 0.414 0.033 DBMET03568 | DBMET03568 | |
| 0.011 | 0.687 | 0.271 | Alpha-glucosidase inhibitor | 0.271 0.175 DBMET03568 | DBMET03568 | |
| 0.019 | 0.712 | 0.097 | DNA polymerase I inhibitor | 0.097 0.09 DBMET03568 | DBMET03568 | |
| 0.022 | 0.72 | 0.337 | Cholesterol antagonist | 0.337 0.07 DBMET03568 | DBMET03568 | |
| 0.008 | 0.708 | 0.215 | Lipid peroxidase inhibitor | 0.215 0.036 DBMET03568 | DBMET03568 | |
| 0.025 | 0.729 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 DBMET03568 | DBMET03568 | |
| 0.01 | 0.892 | 0.304 | Hypoglycemic | 0.304 0.051 DBMET03568 | DBMET03568 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |